Menu

CME Corner

Program Detail

Release Date: March-29-19
Credit Expiration Date: March-29-20

Faculty

PRESENTER
Victoria J. Sinibaldi, RN-C, MS, ARNP, GRNP
Nurse Practitioner Research Program Coordinator, Genitourinary Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Research Associate in Oncology
Research Associate in Urology
The Johns Hopkins University School of Medicine
Baltimore, MD

OTHER CONTRIBUTING FACULTY
Frank dela Rama, RN, MS, AOCNS, AGN-BC
Clinical Nurse Specialist, Oncology/Genomics
CANCER CARE
Palo Alto Medical Foundation
Palo Alto, CA

Brigid S. Miralda, RN, MSN, FNP
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA

Credit Hours

Physicians: 1.0 AMA PRA Category 1 Credit
Nurses: 1 contact hour
NPs: 1 contact hour, which includes 0.6 hours of pharmacology

Medium

Online Presentation

Program Description

Treatment for prostate cancer has expanded and improved in recent years, but many patients continue to live with the long-term sequelae of the disease and treatment-related side effects. There are numerous treatment options available for both hormone-sensitive and castration-resistant metastatic prostate cancer, and oncology nurses must be knowledgeable about these and their wide range of adverse effects. This activity will examine the prevention and management of long and short-term side effects, ADT-related bone loss and the risk of osteoporosis, bone fragility risk in patients with bone metastases, patient education, and individualized supportive care.

Program Developer/Facilitator

This activity is jointly provided by Global Education Group and MCM Education

Target Audience

This educational activity is designed to address the needs of oncology nurses, NPs, and other health care providers who encounter patients with mPRCA.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Outline individualized plans for preventing and managing treatment side effects for patients with metastatic hormone-sensitive prostate cancer using shared decision making.
  2. Outline individualized plans for preventing and managing treatment side effects for patients with metastatic castration-resistant prostate cancer using shared decision making.
  3. Discuss agents used to support bone health in patients with metastatic prostate cancer.
  4. Describe individualized supportive care for patients with metastatic prostate cancer.

Disclosures

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.
Frank dela Rama: Nothing to disclose
Brigid S. Miralda: Nothing to disclose
Victoria J. Sinibaldi: Nothing to disclose

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity
Ashley Marostica, RN, MSN: Nothing to disclose
Kristin Delisi, NP: Nothing to disclose
Lindsay Borvansky: Nothing to disclose
Andrea Funk: Nothing to disclose
Liddy Knight: Nothing to disclose
Ashley Cann: Nothing to disclose
Kathleen Hines: Nothing to disclose

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and MCM Education do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Credit Statements

PHYSICIAN CONTINUING EDUCATION
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and MCM Education. Global is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING CONTINUING EDUCATION
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 1 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and MCM Education. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024. This activity is approved for 1 contact hour, which includes 0.6 hours of pharmacology.
Activity ID #2699E.
This activity was planned in accordance with AANP CE Standards and Policies.

For information about the approval of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com. This activity is jointly
provided by Global Education Group and MCM Education.

Commercial Support Statements

This activity is supported by educational grants from Astellas Pharma US, Sanofi Genzyme, and AbbVie, Inc.

Instructions

Completion Instructions

  1. Accessing Activity:
    * Click "Start Program"
    * Take the pre-test
    * Review the activity
    * Take the post-test and score 80%
    * You are allowed a total of 3 attempts
    * Complete the evaluation
    * View, print, or save a CE certificate verifying your
    credit/participation in this activity
  2. Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers

Certificate Fee

$0.00

There is no charge for CME/CE credit.

Disclaimer

©2019 MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Global Education Group, Astellas Pharma US, Sanofi Genzyme, or AbbVie, Inc. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu
EDITOR'S PICKS